Tiziana Life Sciences , the UK biotechnology company, today announces that it has entered into an exclusive license agreement with TTFactor S.r.l. Institute for Molecular Oncology , and the European Institute of Oncology ), covering the use of twenty defined stem cell markers for patient stratification in breast cancer.
http://ift.tt/1r6Xd7d
http://ift.tt/1r6Xd7d
No comments:
Post a Comment